CD82 and cancer: Tetraspanin CD9 has been shown to regulate expression of MMP9 via the JNK pathway56, 57, and tetraspanin CD82 can inhibit cancer cell retraction and motility via deregulation of the Rac1/RhoA signaling network58, 59.